Put It on the Board, 9/13

Create PDF

Xifin acquires PathCentral

Xifin has acquired the product and service assets and related intellectual property of PathCentral, which provides AP Anywhere, a cloud-based anatomic pathology and molecular diagnostics laboratory information system.

PathCentral also provides an online information exchange and global digital consultation forum (PathCentralPro.net) that enables pathologists to collaborate worldwide using digital pathology technology, social media, and LIS functionality in a single cloud-based platform.

“The acquisition of PathCentral expands our technology platform and advances Xifin’s vision of the open, secure exchange of diagnostic, financial, and clinical information,” Lâle White, CEO of Xifin, said in a statement.

BioMérieux acquires BioFire

BioMérieux has entered into an agreement to acquire BioFire Diagnostics.

BioFire’s FilmArray is a key asset in the development of BioMérieux’s franchise in infectious disease diagnostics, which accounts for 85 percent of sales in clinical applications. On the basis of ongoing R&D, FilmArray should make it possible to detect more than 70 disease agents responsible for respiratory, gastrointestinal, and blood infections within the next three years, according to a statement from BioMérieux.